Coronavirus specialist and USP physician speaks about the new variants of SARS-CoV-2 and the risk they represent in the efficacy of some vaccines
Administering vaccines on a large scaled will tell us whether, in addition to protecting against the disease, they are also able to prevent infection by SARS-CoV-2
Lack of public and private investment heightens the dependence of Brazil and South Africa on vaccines from other countries, unlike the other BRICS members
Research centers working on vaccines for the novel coronavirus in Brazil face major hurdles
Research networks seeking to strengthen dialogue with the public authorities arise in response to the pandemic
